Human health during space travel: state-of-the-art review
C Krittanawong, NK Singh, RA Scheuring, E Urquieta… - Cells, 2022 - mdpi.com
The field of human space travel is in the midst of a dramatic revolution. Upcoming missions
are looking to push the boundaries of space travel, with plans to travel for longer distances …
are looking to push the boundaries of space travel, with plans to travel for longer distances …
Rapidly progressive dementia
GS Day - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
Rapidly Progressive Dementia : CONTINUUM: Lifelong Learning in Neurology Account
Register Activate Subscription Help Subscribe American Academy of Neurology Login …
Register Activate Subscription Help Subscribe American Academy of Neurology Login …
Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease
N Watson, P Hermann, A Ladogana… - JAMA network …, 2022 - jamanetwork.com
Importance Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly lethal disease. Rapid,
accurate diagnosis is imperative for epidemiological surveillance and public health activities …
accurate diagnosis is imperative for epidemiological surveillance and public health activities …
Genetic aspects of human prion diseases
BS Appleby, S Shetty, M Elkasaby - Frontiers in Neurology, 2022 - frontiersin.org
Human prion diseases are rapidly progressive and fatal neurodegenerative conditions
caused by a disease-causing isoform of the native prion protein. The prion protein gene …
caused by a disease-causing isoform of the native prion protein. The prion protein gene …
Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases
W Zhang, CD Orrú, A Foutz, M Ding, J Yuan… - Acta …, 2024 - Springer
Definitive diagnosis of sporadic Creutzfeldt–Jakob disease (sCJD) relies on the examination
of brain tissues for the pathological prion protein (PrPSc). Our previous study revealed that …
of brain tissues for the pathological prion protein (PrPSc). Our previous study revealed that …
The use of real-time quaking-induced conversion for the diagnosis of human prion diseases
A Poleggi, S Baiardi, A Ladogana… - Frontiers in Aging …, 2022 - frontiersin.org
Prion diseases are rapidly progressive, invariably fatal, transmissible neurodegenerative
disorders associated with the accumulation of the amyloidogenic form of the prion protein in …
disorders associated with the accumulation of the amyloidogenic form of the prion protein in …
Clinical use of improved diagnostic testing for detection of prion disease
MP Figgie Jr, BS Appleby - Viruses, 2021 - mdpi.com
Prion diseases are difficult to recognize as many symptoms are shared among other
neurologic pathologies and the full spectra of symptoms usually do not appear until late in …
neurologic pathologies and the full spectra of symptoms usually do not appear until late in …
Application of real-time quaking-induced conversion in Creutzfeldt–Jakob disease surveillance
P Hermann, M Schmitz, M Cramm, S Goebel… - Journal of …, 2023 - Springer
Background Evaluation of the application of CSF real-time quaking-induced conversion in
Creutzfeldt–Jakob disease surveillance to investigate test accuracy, influencing factors, and …
Creutzfeldt–Jakob disease surveillance to investigate test accuracy, influencing factors, and …
MRI abnormalities in Creutzfeldt–Jakob disease and other rapidly progressive dementia
R Manara, F Fragiacomo, A Ladogana, L Vaianella… - Journal of …, 2024 - Springer
Objective To investigate brain MRI abnormalities in a cohort of patients with rapidly
progressive dementia (RPD) with and without a diagnosis of Creutzfeldt–Jakob disease …
progressive dementia (RPD) with and without a diagnosis of Creutzfeldt–Jakob disease …
A discriminative event‐based model for subtype diagnosis of sporadic Creutzfeldt‐Jakob disease using brain MRI
Abstract Introduction Sporadic Creutzfeldt‐Jakob disease (sCJD) comprises multiple
subtypes (MM1, MM2, MV1, MV2C, MV2K, VV1, and VV2) with distinct disease durations …
subtypes (MM1, MM2, MV1, MV2C, MV2K, VV1, and VV2) with distinct disease durations …